BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24945137)

  • 1. Secondary malignancies in pediatric cancer survivors: perspectives and review of the literature.
    Choi DK; Helenowski I; Hijiya N
    Int J Cancer; 2014 Oct; 135(8):1764-73. PubMed ID: 24945137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.
    Travis LB; Demark Wahnefried W; Allan JM; Wood ME; Ng AK
    Nat Rev Clin Oncol; 2013 May; 10(5):289-301. PubMed ID: 23529000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance and monitoring of adult cancer survivors.
    Choi M; Craft B; Geraci SA
    Am J Med; 2011 Jul; 124(7):598-601. PubMed ID: 21683826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of second primary cancers.
    Travis LB
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2020-6. PubMed ID: 17057028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary care of adult survivors of childhood cancer.
    Seehusen DA; Baird D; Bode D
    Am Fam Physician; 2010 May; 81(10):1250-5. PubMed ID: 20507049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A French national breast and thyroid cancer screening programme for survivors of childhood, adolescent and young adult (CAYA) cancers - DeNaCaPST programme.
    Demoor-Goldschmidt C; Drui D; Doutriaux I; Michel G; Auquier P; Dumas A; Berger C; Bernier V; Bohrer S; Bondiau PY; Filhon B; Fresneau B; Freycon C; Stefan D; Helfre S; Jackson A; Kerr C; Laprie A; Leseur J; Mahé MA; Oudot C; Pluchard C; Proust S; Sudour-Bonnange H; Vigneron C; Lassau N; Schlumberger M; Conter CF; de Vathaire F
    BMC Cancer; 2017 May; 17(1):326. PubMed ID: 28499444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secondary cancers: Incidence, risk factors and recommendations].
    Demoor-Goldschmidt C; Fayech C; Girard P; Plantaz D
    Bull Cancer; 2015; 102(7-8):656-64. PubMed ID: 25911942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognizing health risks in childhood cancer survivors.
    Nelson MB; Meeske K
    J Am Acad Nurse Pract; 2005 Mar; 17(3):96-103. PubMed ID: 15748222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature.
    Wasilewski-Masker K; Kaste SC; Hudson MM; Esiashvili N; Mattano LA; Meacham LR
    Pediatrics; 2008 Mar; 121(3):e705-13. PubMed ID: 18310191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
    Rihani R; Bazzeh F; Faqih N; Sultan I
    Cancer; 2010 Sep; 116(18):4385-94. PubMed ID: 20549819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second solid tumors: screening and management guidelines in long-term survivors after allogeneic stem cell transplantation.
    Socié G; Rizzo JD
    Semin Hematol; 2012 Jan; 49(1):4-9. PubMed ID: 22221779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of health conditions identified in a pediatric cancer survivor program.
    Wasilewski-Masker K; Mertens AC; Patterson B; Meacham LR
    Pediatr Blood Cancer; 2010 Jul; 54(7):976-82. PubMed ID: 20108334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Second primary malignancy among cancer survivors - epidemiology, prognosis and clinical relevance].
    Grundmann RT; Meyer F
    Zentralbl Chir; 2012 Dec; 137(6):565-74. PubMed ID: 22426967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivors of childhood cancer: coming of age.
    Hudson MM
    Hematol Oncol Clin North Am; 2008 Apr; 22(2):211-31, v-vi. PubMed ID: 18395146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term mortality from second malignant neoplasms in 5-year survivors of solid childhood tumors: temporal pattern of risk according to type of treatment.
    Tukenova M; Diallo I; Hawkins M; Guibout C; Quiniou E; Pacquement H; Dhermain F; Shamsaldin A; Oberlin O; de Vathaire F
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):707-15. PubMed ID: 20200431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations.
    Travis LB; Rabkin CS; Brown LM; Allan JM; Alter BP; Ambrosone CB; Begg CB; Caporaso N; Chanock S; DeMichele A; Figg WD; Gospodarowicz MK; Hall EJ; Hisada M; Inskip P; Kleinerman R; Little JB; Malkin D; Ng AK; Offit K; Pui CH; Robison LL; Rothman N; Shields PG; Strong L; Taniguchi T; Tucker MA; Greene MH
    J Natl Cancer Inst; 2006 Jan; 98(1):15-25. PubMed ID: 16391368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second malignant neoplasms: assessment and strategies for risk reduction.
    Wood ME; Vogel V; Ng A; Foxhall L; Goodwin P; Travis LB
    J Clin Oncol; 2012 Oct; 30(30):3734-45. PubMed ID: 23008293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary gland tumors in survivors of childhood cancer.
    Whatley WS; Thompson JW; Rao B
    Otolaryngol Head Neck Surg; 2006 Mar; 134(3):385-8. PubMed ID: 16500432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy-induced secondary malignancies.
    Vega-Stromberg T
    J Infus Nurs; 2003; 26(6):353-61. PubMed ID: 14624175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second cancers in survivors of hodgkin lymphoma: risks and recommendations.
    Leahy Y
    Clin J Oncol Nurs; 2008 Jun; 12(3):437-42. PubMed ID: 18515242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.